INAB
In8bio, Inc.Company with tickers: INAB
CIK
1740279
CUSIP
45674E208
Shares Outstanding
9,847,089
13F Activity (30d)
18 filings
18 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $5,660,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $2,972,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-5,550,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-5,550,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-2.16 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-2.16 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |